Zimmer Biomet launches something new outside the US, a subchondroplasty procedure for bone marrow lesions

Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure (press release)

WARSAW, Ind., Feb. 7, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the international release of the Subchondroplasty® (SCP®) Procedure.  The Company received CE Mark approval for the commercialization of its SCP Procedure to facilitate distribution in the European Union (EU) and other countries that recognize the CE Mark.  Zimmer Biomet also received approval for distribution in Canada, Singapor...